Rystiggo

Active Ingredient(s): Rozanolixizumab-noli
FDA Approved: * June 27, 2023
Pharm Company: * UCB INC
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rystiggo 140 mg/ml Subcutaneous Injection, Solution
NDC: 50474-980
Labeler:
Ucb, Inc.